Literature DB >> 28757616

Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?

X Calvo1, L Florensa1, L Arenillas1.   

Abstract

Leukemia accepted article preview online, 31 July 2017. doi:10.1038/leu.2017.237.

Entities:  

Year:  2017        PMID： 28757616     DOI： 10.1038/leu.2017.237

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


  6 in total

1.  Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.

Authors:  C Y Ok; R P Hasserjian; P S Fox; F Stingo; Z Zuo; K H Young; K Patel; L J Medeiros; G Garcia-Manero; S A Wang
Journal:  Leukemia       Date:  2013-06-21       Impact factor: 11.528

2.  Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant.

Authors:  Zeba N Singh; Dezheng Huo; John Anastasi; Sonali M Smith; Theodore Karrison; Michelle M Le Beau; Richard A Larson; James W Vardiman
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

3.  Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium.

Authors:  A M Zeidan; N Al Ali; J Barnard; E Padron; J E Lancet; M A Sekeres; D P Steensma; A DeZern; G Roboz; E Jabbour; G Garcia-Manero; A List; R Komrokji
Journal:  Leukemia       Date:  2017-01-23       Impact factor: 11.528

4.  A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.

Authors:  Alfonso Quintás-Cardama; Naval Daver; Hawk Kim; Courtney Dinardo; Elias Jabbour; Tapan Kadia; Gautam Borthakur; Sherry Pierce; Jianqin Shan; Marylou Cardenas-Turanzas; Jorge Cortes; Farhad Ravandi; William Wierda; Zeev Estrov; Stefan Faderl; Yue Wei; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2014-05-06

5.  Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms.

Authors:  Valentina Nardi; Karen M Winkfield; Chi Young Ok; Andrzej Niemierko; Michael J Kluk; Eyal C Attar; Guillermo Garcia-Manero; Sa A Wang; Robert P Hasserjian
Journal:  J Clin Oncol       Date:  2012-05-14       Impact factor: 44.544

6.  TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.

Authors:  Chi Young Ok; Keyur P Patel; Guillermo Garcia-Manero; Mark J Routbort; Jie Peng; Guilin Tang; Maitrayee Goswami; Ken H Young; Rajesh Singh; L Jeffrey Medeiros; Hagop M Kantarjian; Rajyalakshmi Luthra; Sa A Wang
Journal:  J Hematol Oncol       Date:  2015-05-08       Impact factor: 17.388
  6 in total
  1 in total

1.  Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?

Authors:  A M Zeidan; M A Sekeres; J Barnard; D P Steensma; R Komrokji
Journal:  Leukemia       Date:  2017-07-31       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.